Inventor · disambiguated record
John Paul Guilinger
Also filed as: GUILINGER JOHN · GUILINGER JOHN PAUL
9 granted patents·1 pending application·804 citations·filing 2012–2019
93Inventor score
Top patents by PatentIndex Score
10 records- 0198US11046948B2Engineered transcription activator-like effector (TALE) domains and uses thereofHARVARD COLLEGE·Filed 2019·Granted Jun 29, 2021·64 cites·19 claims
- 0297US10227581B2Engineered transcription activator-like effector (TALE) domains and uses thereofHARVARD COLLEGE·Filed 2014·Granted Mar 12, 2019·86 cites·16 claims
- 0397US9388430B2Cas9-recombinase fusion proteins and uses thereofHARVARD COLLEGE·Filed 2014·Granted Jul 12, 2016·126 cites·7 claims
- 0497US9359599B2Engineered transcription activator-like effector (TALE) domains and uses thereofHARVARD COLLEGE·Filed 2014·Granted Jun 7, 2016·95 cites·28 claims
- 0597US9322037B2Cas9-FokI fusion proteins and uses thereofHARVARD COLLEGE·Filed 2014·Granted Apr 26, 2016·187 cites·10 claims
- 0697US9322006B2Evaluation and improvement of nuclease cleavage specificityHARVARD COLLEGE·Filed 2014·Granted Apr 26, 2016·93 cites·26 claims
- 0796US10858639B2CAS9 variants and uses thereofHARVARD COLLEGE·Filed 2014·Granted Dec 8, 2020·65 cites·23 claims
- 0896US10323236B2Evaluation and improvement of nuclease cleavage specificityLIU DAVID R·Filed 2012·Granted Jun 18, 2019·70 cites·17 claims
- 0995US12006520B2Evaluation and improvement of nuclease cleavage specificityHARVARD COLLEGE·Filed 2019·Granted Jun 11, 2024·18 cites·23 claims
- 1033US2020339562A1Covalent btk inhibitors and uses thereofX CHEM INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when John Paul Guilinger files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →